These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3526609

  • 1. Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease.
    Cronenwett JL, Zelenock GB, Whitehouse WM, Lindenauer SM, Graham LM, Stanley JC.
    Surgery; 1986 Aug; 100(2):369-75. PubMed ID: 3526609
    [Abstract] [Full Text] [Related]

  • 2. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [Abstract] [Full Text] [Related]

  • 3. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Oct; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 4. Possibilities for clinical use of prostacyclin in vascular disease.
    Poredos P.
    Pflugers Arch; 2000 Oct; 440(5 Suppl):R137-8. PubMed ID: 11005643
    [Abstract] [Full Text] [Related]

  • 5. Prostacyclin for ischemic ulcers in peripheral arterial disease. A random assignment, placebo controlled study.
    Nizankowski R, Królikowski W, Bielatowicz J, Szczeklik A.
    Thromb Res; 1985 Jan 01; 37(1):21-8. PubMed ID: 3885472
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
    Belch JJ, McKay A, McArdle B, Leiberman P, Pollock JG, Lowe GD, Forbes CD, Prentice CR.
    Lancet; 1983 Feb 12; 1(8320):315-7. PubMed ID: 6130330
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of ciprostene in patients with peripheral vascular disease (PVD) characterized by ischemic ulcers. The Ciprostene Study Group.
    J Clin Pharmacol; 1991 Jan 12; 31(1):81-7. PubMed ID: 2045533
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Hemodynamics and changes in compliance of the extra-thoracic capacity system following administration of prostacyclin (PGI2)].
    Kramer M, Schleussner E, Schmidt A, Heinrich D, Walter P, Hempelmann G.
    Herz; 1984 Apr 12; 9(2):102-9. PubMed ID: 6370814
    [Abstract] [Full Text] [Related]

  • 14. Intravenous infusion of prostaglandin E1 (PGE1) in management of limb ischemia.
    Sethi GK, Bridgman AH, King L, Scott SM.
    Am Surg; 1986 Sep 12; 52(9):474-8. PubMed ID: 3752724
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
    Powell RJ, Simons M, Mendelsohn FO, Daniel G, Henry TD, Koga M, Morishita R, Annex BH.
    Circulation; 2008 Jul 01; 118(1):58-65. PubMed ID: 18559703
    [Abstract] [Full Text] [Related]

  • 17. The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease.
    Olsson AG, Nilsson E.
    Prostaglandins Med; 1981 Apr 01; 6(4):329-39. PubMed ID: 7025066
    [Abstract] [Full Text] [Related]

  • 18. The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia.
    Belch JJ, Ray S, Rajput-Ray M, Engeset J, Fagrell B, Lepäntalo M, McKay A, Mackay IR, Ostergren J, Ruckley CV, Salenius J.
    Int Angiol; 2011 Apr 01; 30(2):150-5. PubMed ID: 21427652
    [Abstract] [Full Text] [Related]

  • 19. Potential therapeutic mechanisms of stable prostacyclin (PGI2)-mimetics in severe peripheral vascular disease.
    Müller B, Krais T, Stürzebecher S, Witt W, Schillinger E, Baldus B.
    Biomed Biochim Acta; 1988 Apr 01; 47(10-11):S40-4. PubMed ID: 2470358
    [Abstract] [Full Text] [Related]

  • 20. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG, Horsch S.
    Int Angiol; 1996 Dec 01; 15(4):344-9. PubMed ID: 9127776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.